Design Therapeutics Inc

DSGNNASDAQ · USD
12.36USD0.00 (-6.08%)
2210

Design Therapeutics Inc (DSGN) Historical Volatility

DSGN 30-day historical volatility is 55%. This ranks in the 25th percentile of readings over the past year.

Read more

Tracking DSGN historical volatility helps you see how much Design Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Design Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor DSGN 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The DSGN 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Design Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs.

It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Design Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where DSGN HV is running hot, cold, or in line. Make the DSGN 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 23, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 23, 2026

See how volatility has moved over time

Track DSGN historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial